Transdermal and Mucosal Delivery

The skin and mucosal membranes (GI tract, oronasal cavity, pulmonary tract, and the vagina) are dynamic and complex layers involved in the absorption and secretion of a wide range of molecules and is an important target for vaccine development and the treatment of diseases such as cancer, sexually transmitted infections, and pulmonary disorders. Despite advancements made in the field of transdermal and mucosal delivery, there are still challenges and barriers to developing transdermal and mucosal therapeutics. This focus group will provide a forum for discussion in the field of transdermal and mucosal delivery, the challenges/barriers encountered, and novel strategies to overcome these obstacles to develop a successful therapeutic. The “Transdermal and Mucosal Delivery (TMD)” Focus Group (FG) will also provide a dynamic platform for like-minded professionals (whether you are new to the field or an established scientist) from academia, industry, and the government to efficiently exchange ideas related to cutting edge science and technology in the field.

The members of the Focus Group are expected to be paid members of the Controlled Release Society independent of their membership category.

Upcoming Events:

  • Trainee Video Presentation Contest - Submissions due April 1, 2019

Click here to read more!

STAY CONNECTED.

Image removed.

 

Leadership:

Chair
Emmanuel Ho, Ph.D.
Associate Professor - University of Waterloo
emmanuel.ho@uwaterloo.ca
Vice-Chair
Olivia Merkel, Ph.D.
Professor - Ludwig-Maximilians Universitat
olivia.merkel@cup.uni-muenchen.de
Secretary
Laura Ensign-Hodges
Assistant Professor
Johns Hopkins University
Treasurer
Jill Steinbach-Rankins
Assistant Professor
University of Louisville
Industry Representative
Devin McAllister
VP, Research & Development
Micron Biomedical
Media Chair
Yannick Traore
University of Waterloo
Student Representative
Farnaz Minooei
University of Louisville